Regional MeCP2 expression levels in the female MeCP2-deficient mouse brain correlate with specific behavioral impairments

Experimental Neurology

Volumn 239, Issue 1, 2013, Pages 49-59

  Wither, Robert G ^a,b   Lang, Min ^a,b   Zhang, Liang ^a,b,c   Eubanks, James H ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Autism spectrum disorder; Correlational analysis; MeCP2 expression; Phenotypic behavior; Rett Syndrome; X linked condition

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR DISORDER; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; EXPLORATORY BEHAVIOR; FEMALE; HIPPOCAMPUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD;

ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BODY TEMPERATURE; CEREBELLUM; CEREBRAL CORTEX; DATA INTERPRETATION, STATISTICAL; DELTA RHYTHM; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HIPPOCAMPUS; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RETT SYNDROME; SPINAL CORD;

EID: 84867775162     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.09.005     Document Type: Article

References (53)

1. Adler D.A., Quaderi N.A., Brown S.D., Chapman V.M., Moore J., Tate P., Disteche C.M. The X-linked methylated DNA binding protein, MeCP2, is subject to X inactivation in the mouse. Mamm. Genome 1995, 6:491-492.
2. Alvarez-Saavedra M., Antoun G., Yanagiya A., Oliva-Hernandez R., Cornejo-Palma D., Perez-Iratxeta C., Sonenberg N., Cheng H.Y. miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock. Hum. Mol. Genet. 2011, 20:731-751.
3. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MeCP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 1999, 23:185-188.
4. Archer H., Evans J., Leonard H., Colvin L., Ravine D., Christodoulou J., Williamson S., Charman T., Bailey M.E., Sampson J., de Klerk N., Clarke A. Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation. J. Med. Genet. 2007, 44:148-152.
5. Asaka Y., Jugloff D.G., Zhang L., Eubanks J.H., Fitzsimonds R.M. Hippocampal synaptic plasticity is impaired in the MeCP2-null mouse model of Rett Syndrome. Neurobiol. Dis. 2006, 21:217-227.
6. Barkus C., McHugh S.B., Sprengel R., Seeburg P.H., Rawlins J.N., Bannerman D.M. Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. Eur. J. Pharmacol. 2010, 626:49-56.
7. Braunschweig D., Simcox T., Samaco R.C., LaSalle J.M. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and MeCP2-/+ mouse brain. Hum. Mol. Genet. 2004, 13:1275-1286.
8. Calfa G., Hablitz J.J., Pozzo-Miller L. Network hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging. J. Neurophysiol. 2011, 105:1768-1784.
9. Chen R.Z., Akbarian S., Tudor M., Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 2001, 27:327-331.
10. D'Cruz J.A., Wu C., Zahid T., El-Hayek Y., Zhang L., Eubanks J.H. Alterations of cortical and hippocampal EEG activity in MeCP2-deficient mice. Neurobiol. Dis. 2010, 38:8-16.
11. de Andrés I., Garzón M., Reinoso-Suárez F. Functional anatomy of non-REM sleep. Front. Neurol. 2011, 2:70.
12. El-Hayek Y.H., Wu C., Chen R., Al-Sharif A.R., Huang S., Patel N., Du C., Ruff C.A., Fehlings M.G., Carlen P.L., Zhang L. Acute postischemic seizures are associated with increased mortality and brain damage in adult mice. Cereb. Cortex 2011, 21:2863-2875.
13. Gemelli T., Berton O., Nelson E.D., Perrotti L.I., Jaenisch R., Monteggia L.M. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol. Psychiatry 2006, 59:468-476.
14. Glaze D.G. Neurophysiology of Rett syndrome. J. Child Neurol. 2005, 20:740-746.
15. Goffin D., Allen M., Zhang L., Amorim M., Wang I.T., Reyes A.R., Mercado-Berton A., Ong C., Cohen S., Hu L., Blendy J.A., Carlson G.C., Siegel S.J., Greenberg M.E., Zhou Z. Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat. Neurosci. 2011, 15:274-283.
16. Guy J., Hendrich B., Holmes M., Martin J.E., Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett Syndrome. Nat. Genet. 2001, 27:322-326.
17. Guy J., Gan J., Selfridge J., Cobb S., Bird A. Reversal of neurological defects in a mouse model of Rett Syndrome. Science 2007, 315:1143.
18. Hagberg B. Clinical delineation of Rett syndrome variants. Neuropediatrics 1995, 26:62.
19. Hagberg B.A., Skjeldal O.H. Rett variants: a suggested model for inclusion criteria. Pediatr. Neurol. 1994, 11:5-11.
20. Hagberg B., Aicardi J., Dias K., Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett Syndrome: report of 35 cases. Ann. Neurol. 1983, 14:471-479.
21. Heard E., Disteche C.M. Dosage compensation in mammals: fine-tuning the expression of the X chromosome. Genes Dev. 2006, 20:1848-1867.
22. Hellon R.F., Taylor D.C. An analysis of a thermal afferent pathway in the rat. J. Physiol. 1982, 326:319-328.
23. Ishii T., Makita Y., Ogawa A., Amamiya S., Yamamoto M., Miyamoto A., Oki J. The role of different X-inactivation pattern on the variable clinical phenotype with Rett syndrome. Brain Dev. 2001, (Suppl. 1):S161-S164.
24. Jentarra G.M., Olfers S.L., Rice S.G., Srivastava N., Homanics G.E., Blue M., Naidu S., Narayanan V. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation. BMC Neurosci. 2010, 11:19.
25. Jugloff D.M., Vandamme K., Logan R., Visanji N.P., Brotchie J.M., Eubanks J.H. Targeted delivery of and MeCP2 transgene to forebrain neurons improves the behaviour of female MeCP2-deficient mice. Hum. Mol. Genet. 2008, 17:1386-1396.
26. Julu P.O., Kerr A.M., Apartopoulos F., Al-Rawas S., Engerström I.W., Engerström L., Jamal G.A., Hansen S. Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder. Arch. Dis. Child. 2001, 85:29-37.
27. Kaufmann W.E., Tierney E., Rohde C.A., Suarez-Pedraza M.C., Clarke M.A., Salorio C.F., Bibat G., Bukelis I., Naram D., Lanham D.C., Naidu S. Social impairments in Rett syndrome: characteristics and relationship with clinical severity. J. Intellect. Disabil. Res. 2011, 56:233-247.
28. Kerr B., Alvarez-Saavedra M., Sáez M.A., Saona A., Young J.I. Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice. Hum. Mol. Genet. 2008, 17:1707-1717.
29. Klein M.E., Lioy D.T., Ma L., Impey S., Mandel G., Goodman R.H. Homeostatic regulation of MeCP2 expression by CREB-induced microRNA. Nat. Neurosci. 2007, 10:1513-1514.
30. McHugh S.B., Deacon R.M., Rawlins J.N., Bannerman D.M. Amygdala and ventral hippocampus contribute differentially to mechanisms of fear and anxiety. Behav. Neurosci. 2004, 118:63-78.
31. Park D.M., Zhuang Z., Chen L., Szerlip N., Maric I., Li J., Sohn T., Kim S.H., Lubensky I.A., Vortmeyer A.O., Rodgers G.P., Oldfield E.H., Lonser R.R. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells. PLoS Med. 2007, 4:e60.
32. Paz C., Reygadas E., Fernández-Guardiola A. Sleep alterations following total cerebellectomy in cats. Sleep 1982, 5:218-226.
33. Pelka G.J., Watson C.M., Radziewic T., Hayward M., Lahooti H., Christodoulou J., Tam P.P. Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain 2006, 129:887-898.
34. Petel-Galil Y., Ben-Zeev B., Greenbaum I., Vecsler M., Goldman B., Lohi H., Minassian B.A., Gak E. Comprehensive diagnosis of Rett's syndrome relying on genetic, epigenetic and expression evidence of deficiency of the methyl-CpG-binding protein 2 gene: study of a cohort of Israeli patients. J. Med. Genet. 2007, 44:e56. (Erratum in: J Med Genet. 2007 Feb;44(2):147).
35. Refinetti R., Carlisle H.J. Effects of lateral hypothalamic lesions on thermoregulation in the rat. Physiol. Behav. 1986, 38:219-228.
36. Rexach J.E., Rogers C.J., Yu S.H., Tao J., Sun Y.E., Hsieh-Wilson L.C. Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags. Nat. Chem. Biol. 2010, 6:645-651.
37. Samaco R.C., Fryer J.D., Ren J., Fyffe S., Chao H.T., Sun Y., Greer J.J., Zoghbi H.Y., Neul J.L. A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome. Hum. Mol. Genet. 2008, 17:1718-1727.
38. Shahbazian M.D., Sun Y., Zoghbi H.Y. Balanced X chromosome inactivation patterns in the Rett syndrome brain. Am. J. Med. Genet. 2002, 111:164-168.
39. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., Armstrong D., Paylor R., Zoghbi H. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35:243-254.
40. Singleton M.K., Gonzales M.L., Leung K.N., Yasui D.H., Schroeder D.I., Dunaway K., LaSalle J.M. MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturation. Neurobiol. Dis. 2011, 43:190-200.
41. Sirianni N., Naidu S., Pereira J., Pillotto R.F., Hoffman E.P. Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am. J. Hum. Genet. 1998, 63:1552-1558.
42. Skene P.J., Illingworth R.S., Webb S., Kerr A.R., James K.D., Turner D.J., Andrews R., Bird A.P. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 2010, 37:457-468.
43. Visanji N.P., Millan M.J., Brotchie J.M. Action at sites other than D(3) receptors mediate the effects of BP897 on L-DOPA-induced hyperactivity in monoamine-depleted rats. Exp. Neurol. 2006, 202:85-92.
44. Wan M., Lee S.S., Zhang X., Houwink-Manville I., Song H.R., Amir R.E., Budden S., Naidu S., Pereira J.L., Lo I.F., Zoghbi H.Y., Schanen N.C., Francke U. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am. J. Hum. Genet. 1999, 65:1520-1529.
45. Ward C.S., Arvide E.M., Huang T.W., Yoo J., Noebels J.L., Neul J.L. MeCP2 is critical within HoxB1-derived tissues of mice for normal lifespan. J. Neurosci. 2011, 31:10359-10370.
46. Weaving L.S., Williamson S.L., Bennetts B., Davis M., Ellaway C.J., Leonard H., Thong M.K., Delatycki M., Thompson E.M., Laing N., Christodoulou J. Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype. Am. J. Med. Genet. A 2003, 118A:103-114.
47. Weese-Mayer D.E., Lieske S.P., Boothby C.M., Kenny A.S., Bennett H.L., Silvestri J.M., Ramirez J.M. Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome. Pediatr. Res. 2006, 60:443-449.
48. Weiergräber M., Henry M., Hescheler J., Smyth N., Schneider T. Electrocorticographic and deep intracerebral EEG recording in mice using a telemetry system. Brain Res. Protocol. 2005, 14:154-164.
49. Wither R.G., Colic S., Wu C., Bardakjian B.L., Zhang L., Eubanks J.H. Daily rhythmic behaviors and thermoregulatory patterns are disrupted in adult female MeCP2-deficient mice. PLoS One 2012, 7:e35396.
50. Young J.I., Zoghbi H.Y. X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of Rett syndrome. Am. J. Hum. Genet. 2004, 74:511-520.
51. Zhang L., He J., Jugloff D.G., Eubanks J.H. The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus 2008, 18:294-309.
52. Zhou Z., Hong E.J., Cohen S., Zhao W.N., Ho H.Y., Schmidt L., Chen W.G., Lin Y., Savner E., Griffith E.C., Hu L., Steen J.A., Weitz C.J., Greenberg M.E. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 2006, 52:255-269.
53. Zhu X., Li M., Pan H., Bao X., Zhang J., Wu X. Analysis of the parental origin of de novo MECP2 mutations and X chromosome inactivation in 24 sporadic patients with Rett syndrome in China. J. Child Neurol. 2010, 25:842-848.